Do Hung
Chief Science Officer at FOLD
- Sold, on record
- $11.1M
- Dollars the filings state
- Form 4 sales
- 17
- Latest Dec 14, 2020
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- FOLDAMICUS THERAPEUTICS, INC.Chief Science Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale FOLDPlan not statedOct 12 2017
Sold 50,194 shares at $14.25 ($715k)
Do Hung, Chief Science Officer
Sold 9.6% of holdings ($7.5M position)473,207 shares left2x usual sizeFiling
- 2 Form 4 sale FOLDPlan not statedApr 17 +187 days
Sold 50,000 shares at $15.00 ($750k)
Do Hung, Chief Science Officer
Sold 10.1% of holdings ($7.5M position)446,771 shares left2x usual sizeFiling
- 3 Form 4 sale FOLDPlan not statedMay 16 +29 days
Sold 25,000 shares at $15.00 ($375k)
Do Hung, Chief Science Officer
Sold 5.6% of holdings ($6.7M position)421,771 shares left1x usual sizeFiling
- 4 Form 4 sale FOLDPlan not statedJun 1 +16 days
Sold 25,000 shares at $16.72 ($418k)
Do Hung, Chief Science Officer
Sold 5.9% of holdings ($7.1M position)396,771 shares left1x usual sizeFiling
- 5 Form 4 sale FOLDPlan not statedJan 16 +229 days
Sold 53,269 shares at $12.03 ($641k)
Do Hung, Chief Science Officer
Sold 10.8% of holdings ($5.9M position)438,268 shares left1.8x usual sizeFiling
- 6 Form 4 sale FOLDPlan not statedFeb 12 +392 days
Sold 63,356 shares at $11.01 ($698k)
Do Hung, Chief Science Officer
Sold 11% of holdings ($6.3M position)510,899 shares left1.7x usual sizeFiling
- 7 Form 4 sale FOLDUnusualOct 9 +240 days
Sold 193,700 shares at $15.03 ($2.9M)
Do Hung, Chief Science Officer
Sold 27.1% of holdings ($10.7M position)520,807 shares leftFiling
- 8 Form 4 sale FOLDPlan not statedDec 14 +66 days
Sold 111,125 shares at $23.88 ($2.7M)
Do Hung, Chief Science Officer
Sold 21.3% of holdings ($12.4M position)409,682 shares left1.8x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (17)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Dec 14, 2020 | FOLD | Chief Science Officer | Form 4 sale | 111,125 | $2.7M | 21.3% | Plan not stated | SEC |
| Oct 9, 2020 | FOLD | Chief Science Officer | Form 4 sale | 193,700 | $2.9M | 27.1% | Unusual | SEC |
| Feb 12, 2020 | FOLD | Chief Science Officer | Form 4 sale | 63,356 | $698k | 11.0% | Plan not stated | SEC |
| Jan 16, 2019 | FOLD | Chief Science Officer | Form 4 sale | 53,269 | $641k | 10.8% | Plan not stated | SEC |
| Jun 1, 2018 | FOLD | Chief Science Officer | Form 4 sale | 25,000 | $418k | 5.9% | Plan not stated | SEC |
| May 16, 2018 | FOLD | Chief Science Officer | Form 4 sale | 25,000 | $375k | 5.6% | Plan not stated | SEC |
| Apr 17, 2018 | FOLD | Chief Science Officer | Form 4 sale | 50,000 | $750k | 10.1% | Plan not stated | SEC |
| Oct 12, 2017 | FOLD | Chief Science Officer | Form 4 sale | 50,194 | $715k | 9.6% | Plan not stated | SEC |
| May 19, 2017 | FOLD | Chief Science Officer | Form 4 sale | 29,914 | $239k | 5.9% | Plan not stated | SEC |
| May 15, 2017 | FOLD | Chief Science Officer | Form 4 sale | 29,914 | $239k | 5.6% | Plan not stated | SEC |
| Feb 7, 2017 | FOLD | Chief Science Officer | Form 4 sale | 25,000 | $150k | 4.5% | Plan not stated | SEC |
| Jan 13, 2017 | FOLD | Chief Science Officer | Form 4 sale | 25,000 | $150k | 4.3% | Plan not stated | SEC |
| Nov 1, 2016 | FOLD | Chief Science Officer | Form 4 sale | 25,000 | $175k | 4.5% | Plan not stated | SEC |
| Oct 3, 2016 | FOLD | Chief Science Officer | Form 4 sale | 25,000 | $181k | 4.3% | Plan not stated | SEC |
| Sep 6, 2016 | FOLD | Chief Science Officer | Form 4 sale | 25,000 | $175k | 4.1% | Plan not stated | SEC |
| Aug 4, 2016 | FOLD | Chief Science Officer | Form 4 sale | 25,000 | $175k | 3.9% | Plan not stated | SEC |
| Sep 15, 2015 | FOLD | Chief Science Officer | Form 4 sale | 25,000 | $444k | 3.4% | Plan not stated | SEC |